Overexpression of NCBP2 was associated with poor prognosis, especially in early-stage patients with pancreatic cancer.322 There is a study indicated that the expression of NCBP2 is upregulated in various types of malignant tumors, including OSCC. The gene discussed is NCBP2; the disease is familial pancreatic carcinoma.